# Eribulin Mesylate

NDC: 81298-3890
Generic name: Eribulin Mesylate
Labeler / Manufacturer: Long Grove Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SOLUTION
Routes: INTRAVENOUS
Marketing started: 20240722

FDA application: ANDA214850

## Active ingredients

- ERIBULIN MESYLATE: .5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"81298-3890"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=81298-3890
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4a64918a-f674-4843-b544-ab815fdd1b8f